visceral leishmaniasis: an update and literature review
نویسندگان
چکیده
conclusions development of novel drugs and diagnostic tests has allowed us to better manage vl. although leishmaniasis is one of the oldest known parasitic infectious diseases, increasing prevalence of vl among specific populations, recent reports of disease reactivation and flare-up in clinically asymptomatic patients after the onset of immunosuppressive therapy, the risk of disease acquisition by tourists in endemic areas (e.g., the mediterranean eara), and difficulties in prevention and controlling disease (i.e., given the diversity and distribution of vectors and reservoirs), leishmaniasis has again attracted researchers’ attention. concerning reports of treatment failure and drug resistance are also new challenges in management of this parasitic disease in endemic areas. context leishmania is a pathogen that infects mononuclear phagocytes in which they establish chronic intracellular parasitism and survive for the infected person’s lifetime. untreated cases of visceral leishmaniasis (vl) could cause death within two years. along with known complications of vl, co-infection of leishmania with human immunodeficiency virus (hiv) is becoming more frequent, with important clinical, diagnostic, chemotherapeutic, epidemiologic, and economic implications. this review attempts to provide updated information about diagnosis and treatment of vl. evidence acquisition in this narrative review, recent published sources of information on leishmaniasis consisting of books and articles have been reviewed. this review focuses on vl. results the outcome of infection depends on the host, the leishmania species, and co-morbidities or co-infections. disease manifestation may range from asymptomatic carrier to fatal disease. the development of a sensitive and rapid antigen detection test for relapse detection and also for cure remains an important aspect in diagnosis.
منابع مشابه
Visceral leishmaniasis: an update of laboratory diagnosis
Visceral leishmaniasis (VL), is an infection due to obligate intracellular protozoa of the genus Leishmania[1]. Natural transmission of the parasite happens primarilyby way ofthe bite of contaminated female of phlebotome. In the Old World it is represented by the genus Phlebotomous but in the New World it is called Lutzomyia. Another way of transmission may occur among the intravenous drug abus...
متن کاملEpidemiology of Visceral Leishmaniasis in Algeria: An Update
Visceral leishmaniasis (VL), a zoonotic disease caused by Leishmania infantum, is endemic in Algeria. This report describes a retrospective epidemiological study conducted on human VL to document the epidemiological profile at national level. All human VL cases notified by the National Institute of Public Health between 1998 and 2008 were investigated. In parallel all VL cases admitted to the u...
متن کاملVisceral leishmaniasis diagnosed by biopsy of an axillary lymph node: case report and literature review
A 56-year-old man presented with fevers up to 40°C and acute pain in the left upper quadrant. Full blood count was normal and biochemical tests revealed increased serum globulin. Abdominal ultrasound revealed hepatomegaly and splenomegaly with multiple enlarged lymph nodes in the neck, axilla, and inguinal regions. The bone marrow smear was negative. Splenectomy was performed and the pathology ...
متن کاملIndian visceral leishmaniasis with extensive lymphadenopathy – An unusual presentation: A case report with literature review
Visceral leishmaniasis (VL), also known as kala-azar, is a life-threatening systemic disease caused by the obligate intracellular protozoan, Leishmania, and transmitted to humans by the female phlebotomine sand fly (Phlebotomus argentipes). The disease is fatal, if left untreated. We report a case of a patient clinically suspected of disseminated tuberculosis, but fine needle aspiration cytolog...
متن کاملNewer Drugs for Visceral Leishmaniasis: a Review
Visceral Leishmaniasis (VL) is one of the most neglected tropical diseases worldwide. The diagnosis and treatment of this disease is quite complex. Sodium Antimony Gluconate (SAG) which used to be a very effective treatment has now developed resistance and is potentially a cardio-toxic drug. Pentamidine has now been discarded because of adverse effect of diabetes mellitus. Amphotericin-B is an ...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
archives of pediatric infectious diseasesجلد ۴، شماره ۳، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023